Sarepta Therapeutics, Inc. (SRPT)
22.69
-0.39
(-1.69%)
USD |
NASDAQ |
Apr 08, 12:57
Sarepta Therapeutics Cash from Investing (TTM) : 69.64M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Keros Therapeutics, Inc. | -1.551M |
| Merck & Co., Inc. | -13.74B |
| PTC Therapeutics, Inc. | -861.98M |
| Gilead Sciences, Inc. | -4.793B |
| REGENXBIO, Inc. | -15.87M |